Couverture de Rare Disease Report

Rare Disease Report

Rare Disease Report

De : Rare Disease Report
Écouter gratuitement

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

 Hosted by HCPLive, the monthly series tackles the intricate details of the 6,000-plus known rare diseases, featuring an expert guest, one disease at a time. Hygiène et vie saine Maladie et pathologies physiques Science
Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Épisodes
    • S2 Ep8: The FDA Decision for Pompe Disease Therapy

      S2 Ep8: The FDA Decision for Pompe Disease Therapy
      Oct 28 2022
      The FDA is expected to announce the final decision for the dual therapy AT-GAA, which uses miglustat in combination with cipaglucosidase alfa for treating Pompe disease, an inherited and often times fatal disorder. Expert Barry Byrne discusses the characteristics of the condition and what this FDA decision will mean for treatment.
      Afficher plus Afficher moins
      13 min
    • S2 Ep7: Newborn Screening Awareness & Novel Diagnostic Tool

      S2 Ep7: Newborn Screening Awareness & Novel Diagnostic Tool
      Oct 10 2022
      In the wake of Newborn Screening Awareness Month, this episode dives into a novel diagnostic precision medicine guidance tool called BeginNGS. Catherine Nester, RN, and Dr. Stephen Kingsmore, discuss the pivotal role of newborn screening in diagnosing rare diseases. As representatives from collaborating partners Inozyme Pharma and Rady Children's Institute that created this tool, they explain the impact that BeginNGS can have on the future of rare disease medicine.
      Afficher plus Afficher moins
      21 min
    • S2 Ep6: CDKL5 Deficiency Disorder Expert Interview

      S2 Ep6: CDKL5 Deficiency Disorder Expert Interview
      Sep 2 2022
      The second episode of the 2-part Rare Disease Report shifts to a clinical perspective with the expertise of Dr. Pestana, a pediatric epileptologist at the Epilepsy Center, Cleveland Clinic Neurological Institute who treats patients with CDKL5 deficiency disorder (CDD).
      Afficher plus Afficher moins
      19 min
    Aucun commentaire pour le moment